Letrozole is an aromatase inhibitor primarily utilized in the treatment of various hormone-responsive breast cancers. It functions by decreasing the amount of estrogen the body produces, which is crucial in the growth of certain types of breast tumors.
Letrozole is a medication commonly used to treat breast cancer in postmenopausal women. It is also sometimes used off-label to help stimulate ovulation in women struggling with infertility. To learn more about Letrozole and its uses, visit Letrozole.
Primary Indications for Letrozole
- Breast Cancer Treatment: Letrozole is mainly prescribed for the adjuvant treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often recommended after surgery and may follow treatment with medications like tamoxifen.
- Advanced Breast Cancer: The medication is also approved for the treatment of locally advanced or metastatic breast cancer in postmenopausal women who have progressed following antiestrogen therapy.
- Infertility Treatment: Off-label, letrozole is used to induce ovulation in women with polycystic ovary syndrome (PCOS) who are experiencing difficulties conceiving.
Mechanism of Action
Letrozole works by inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogens. Lower estrogen levels result in reduced stimulation of estrogen-dependent tumors and can also promote ovulation in women with fertility issues.
Side Effects and Considerations
As with any medication, letrozole may cause side effects. Commonly reported side effects include:
- Hot flashes
- Joint pain
- Fatigue
- Nausea
- Bone density loss
Patients should consult their healthcare provider for a complete list of potential side effects and to discuss whether letrozole is an appropriate treatment option for their condition.
Conclusion
Letrozole has proven to be a valuable medication in the management of breast cancer and as a fertility treatment option. Its use must always be guided by a healthcare professional to ensure the best possible outcomes for patients.
